EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy

Muhammed İsmet Sekmen, Timur Koca iD, Durmuş Ali Çetmi iD, Yılmaz Bilek, Rahmi Atıl Aksoy iD, İsmail Hakkı Sarpün, Aylin Fidan Korcum, Nina Tunçel

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70418 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Muhammed İsmet Sekmen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Radiotherapy, Intensity-Modulated, Radiotherapy Planning, Computer-Assisted, Organs at Risk. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This retrospective, exploratory study evaluated the dosimetric comparison and feasibility of simultaneous integrated boost (SIB) delivered with volumetric modulated arc therapy (VMAT) and helical tomotherapy (HT) in patients with locally advanced cervical cancer ineligible for brachytherapy (BRT).

Methods

This exploratory study involved dosimetric treatment planning based on data from 10 patients diagnosed with locally advanced cervical cancer. SIB plans delivering 77.5 Gy to the primary tumor and 45 Gy to elective regions in 25 fractions were generated using VMAT and HT techniques. SIB plans were created using the VMAT technique in the Monaco 5.51 treatment planning system (TPS) (Elekta, Stockholm, Sweden) and the HT technique in the Precision 3.3.1 TPS (Accuray, Madison, Wisconsin, USA). Planning target volume (PTV) coverage, organ‐at‐risk (OAR) doses, and dose–volume metrics of SIB plans were compared between the VMAT and HT techniques using appropriate statistical tests.

Results

The median PTV77.5 volume was 83.4 cc (range: 14.9–218.2 cc). For PTV77.5, HT yielded a higher mean dose (79.52 Gy vs. 77.54 Gy, p = 0.001) and a superior conformity index (0.81 vs. 0.71, p < 0.001). Bladder dose metrics were significantly lower with HT, including V53.28 Gy (5.66% vs. 10.31%; p = 0.006) and D 2cc (66.47 Gy vs. 70.60 Gy; p < 0.05), while bowel V36.89 Gy volume was also reduced (94.03 cc vs. 115.13 cc; p = 0.038). No statistically significant differences were observed in rectal, sigmoid, or femoral head dose parameters. Beam‐on time was significantly longer for HT than for VMAT (11.0 min vs. 3.4 min, p = 0.005).

Conclusions

BRT remains the standard of care for cervical cancer. For patients ineligible for BRT, SIB is dosimetrically feasible; in this exploratory planning study, HT‐SIB provided better target coverage and OAR sparing than VMAT‐SIB. Prospective multicenter validation is necessary before wider clinical adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedOrgans at RiskHumansFemaleRadiotherapy DosageBrachytherapyRetrospective StudiesMiddle Aged

Stichwörter der Autor:innen

VMATcervical cancerradiotherapysimultaneous integrated boosttomotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Department of Radiation Oncology, Izmir City Hospital, Izmir, Turkey.

ORCID-Profile: Timur Koca, Durmuş Ali Çetmi, Rahmi Atıl Aksoy

Zitieren

APA

Sekmen, M. İ., Koca, T., Çetmi, D. A., Bilek, Y., Aksoy, R. A., Sarpün, İ. H., Korcum, A. F., & Tunçel, N. (2026). Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70418

Vancouver

Sekmen Mİ, Koca T, Çetmi DA, Bilek Y, Aksoy RA, Sarpün İH, et al. Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70418

BibTeX
@article{Sekmen2026,
  author = {Sekmen, Muhammed İsmet and Koca, Timur and Çetmi, Durmuş Ali and Bilek, Yılmaz and Aksoy, Rahmi Atıl and Sarpün, İsmail Hakkı and Korcum, Aylin Fidan and Tunçel, Nina},
  title = {Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70418}
}
Kostenlos starten →